|
Status |
Public on Sep 18, 2023 |
Title |
Whole genome microarray gene expression profiling of transgenic mouse hearts with four-fold increased BBLN contents |
Organism |
Mus musculus |
Experiment type |
Expression profiling by array
|
Summary |
The study performed whole genome microarray gene expression profiling of mouse hearts from BBLN-transgenic mice with four-fold increased cardiac BBLN (Bublin coiled coil protein) contents (Tg-BBLN-low) in comparison to non-transgenic FVB hearts. Tg-BBLN-low mice with four-fold increased cardiac BBLN expression under control of the myocardium-specific alpha-MHC promoter developed features of compensated heart failure with increasing age, which was characterized by a significantly reduced left ventricular ejection fraction as determined by echocardiography. To investigate the compensated heart failure phenotype of Tg-BBLN-low mice, whole genome micoarray gene expression profiling was performed. The microarray data show that moderately increased cardiac BBLN levels are sufficient to induce features of pathological cardiac remodeling.
|
|
|
Overall design |
Whole genome microarray gene expression profiling was performed of mouse hearts from BBLN-transgenic mice with four-fold increased BBLN-contents. Hearts were isolated from eight-month-old, male Tg-BBLN-low mice and from male, age-matched non-transgenic FVB mice, which were used as controls.
|
|
|
Contributor(s) |
Abd Alla J, Quitterer U |
Citation(s) |
38666071 |
|
Submission date |
Aug 16, 2023 |
Last update date |
May 10, 2024 |
Contact name |
Ursula Quitterer |
E-mail(s) |
ursula.quitterer@pharma.ethz.ch
|
Phone |
+41-446329801
|
Organization name |
ETH Zurich
|
Department |
Molecular Pharmacology
|
Street address |
Winterthurerstrasse 190
|
City |
Zurich |
ZIP/Postal code |
CH-8057 |
Country |
Switzerland |
|
|
Platforms (1) |
GPL1261 |
[Mouse430_2] Affymetrix Mouse Genome 430 2.0 Array |
|
Samples (4)
|
|
Relations |
BioProject |
PRJNA1006074 |